Clinical Trials Browser

INDUSTRY × Carcinoma, Medullary × Sorafenib × Clear all

NCT02114658 2017-08-03

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Phase 2 Completed

Thyroid Neoplasms, Carcinoma, Medullary